Follow-up After Suction Evacuation for Molar Pregnancy with β-hCG >200,000 IU/L
After suction evacuation of a molar pregnancy with β-hCG >200,000 IU/L, you must initiate strict serial β-hCG monitoring every 2 weeks until normalization, followed by monthly monitoring for 6 months after normalization, with a low threshold to start chemotherapy if hCG plateaus, rises, or remains >20,000 IU/L at 4 weeks post-evacuation. 1
Immediate Post-Evacuation Management
Initial Assessment
- Measure serum β-hCG immediately after evacuation to establish baseline 2
- Perform pelvic Doppler ultrasound to confirm complete evacuation and assess uterine vascularity 1
- Obtain chest X-ray to screen for pulmonary metastases 1
- Ensure Rh-negative patients receive anti-D immunoglobulin 1
β-hCG Surveillance Protocol
The cornerstone of follow-up is rigorous β-hCG monitoring:
- Weeks 1-8: Measure serum β-hCG every 2 weeks until normal 1, 2
- After normalization: Continue monthly measurements
Critical point: With an initial β-hCG >200,000 IU/L (>2 lakh), this patient is at significantly elevated risk for developing gestational trophoblastic neoplasia (GTN), occurring in approximately 15% of complete moles 1.
Indications for Chemotherapy (Red Flags)
You must initiate chemotherapy immediately if any of the following occur 1:
- Plateaued hCG: Four or more equivalent values over ≥3 weeks (days 1,7,14,21)
- Rising hCG: Two consecutive rises of ≥10% over ≥2 weeks (days 1,7,14)
- hCG ≥20,000 IU/L at 4 weeks post-evacuation (critical for this patient given the high initial level—this indicates high risk of uterine perforation and unlikely spontaneous remission)
- Heavy vaginal bleeding requiring transfusion
- Evidence of metastases (brain, liver, GI tract, or lung lesions >2 cm on chest X-ray)
- Histological evidence of choriocarcinoma
Important nuance: The guideline previously required chemotherapy for elevated hCG at 6 months even if falling, but this has been overturned 1. Recent evidence shows 86-98% of patients with falling hCG at 6 months will spontaneously normalize without chemotherapy 5, 6. However, given your patient's extremely high initial β-hCG (>200,000), maintain heightened vigilance.
Additional Imaging if GTN Suspected
If hCG plateaus/rises or meets chemotherapy criteria 1:
- Pelvic Doppler ultrasound (assess uterine vascularity—high pulsatility index predicts methotrexate resistance)
- Chest CT only if chest X-ray shows lesions >1 cm
- Brain MRI if chest lesions present or neurological symptoms
- Abdominal CT if widespread disease suspected
Do NOT routinely perform chest CT if chest X-ray is normal—micrometastases in ~40% of patients don't change management 1.
Contraception During Follow-up
- Mandatory: Effective contraception throughout the entire surveillance period 4
- Hormonal contraception is preferred to maintain reliability of hCG as tumor marker 7
- Pregnancy during surveillance makes hCG interpretation impossible and delays GTN diagnosis
Common Pitfalls to Avoid
Don't wait too long with high hCG: With initial β-hCG >200,000 IU/L, if hCG remains ≥20,000 at 4 weeks, start chemotherapy immediately—don't wait for plateau/rise 1
Don't perform routine CT chest: Only indicated if chest X-ray abnormal 1
Don't discharge early: Even if hCG normalizes quickly, complete the full 6-month surveillance—risk of late GTN exists, though very low (1:2000) 1
Don't ignore falling but persistent hCG at 6 months: While most will normalize spontaneously 5, 6, continue close monitoring rather than automatic chemotherapy
Don't forget future pregnancy surveillance: After completing follow-up, measure hCG 8 weeks after any future pregnancy event 4
Prognosis
With appropriate surveillance and timely intervention, cure rates approach 100% for low-risk GTN and 94% for high-risk GTN 3. The key is catching progression early through meticulous β-hCG monitoring.